本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

4.91
-0.4300-8.05%
盘后4.85-0.0600-1.22%19:39 EDT
成交量:12.84万
成交额:64.03万
市值:3,038.41万
市盈率:-0.56
高:5.34
开:5.30
低:4.80
收:5.34
52周最高:13.69
52周最低:4.80
股本:618.82万
流通股本:364.12万
量比:0.92
换手率:3.53%
股息:- -
股息率:- -
每股收益(TTM):-8.6984
每股收益(LYR):-2.4500
净资产收益率:-121.86%
总资产收益率:-55.56%
市净率:0.96
市盈率(LYR):-2.00

数据加载中...

2025/03/10

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/10

重要事件披露

Form 8-K - Current report
2025/02/12

重要事件披露

Form 8-K - Current report
2025/02/03

重要事件披露

Form 8-K - Current report
2024/11/15

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/09/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/05

重要事件披露

Form 8-K - Current report
2024/08/20

重要事件披露

Form 8-K - Current report
2024/08/09

重要事件披露

Form 8-K - Current report
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report